| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $22.7M | +13.3% |
| Cost of Revenue | $2.2M | +18.3% |
| Gross Profit | $20.5M | +12.8% |
| R&D Expense | $5.3M | +37.8% |
| SG&A Expense | $14.1M | -8.9% |
| Operating Income | $1.1M | +193.0% |
| Pre-tax Income | $1.3M | +250.4% |
| Income Tax | $58K | +75.8% |
| Net Income | $1.3M | +238.7% |
| EPS (Basic) | $0.07 | +240.0% |
| EPS (Diluted) | $0.06 | +220.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.7M | +106.8% |
| Accounts Receivable | $3.4M | -28.0% |
| Current Assets | $13.9M | +40.3% |
| Total Assets | $24.5M | +16.9% |
| Current Liabilities | $3.8M | +18.8% |
| Total Liabilities | $3.8M | +18.8% |
| Stockholders' Equity | $20.7M | +16.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.5M | +268.6% |
| Capital Expenditures | $52K | -8.8% |
| Investing Cash Flow | -$265K | -109.2% |
| Financing Cash Flow | $708K | +46.0% |
| Free Cash Flow | $4.5M | +263.2% |